Anna Spreafico
Toronto, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 194 publications
Metastatic patterns, outcomes, and prognostic factors in de novo metastatic head and neck cancer by tumor HPV status.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: June 16, 2026
Immune checkpoint blockade sensitivity is linked to endogenous retroelement transcriptional changes in cancer.
Journal: Cancer immunology research
Published: May 12, 2026
Immune profiling by bulk RNA-seq and multiplex immunofluorescence imaging across multiple cancer types.
Journal: Frontiers in oncology
Published: May 09, 2026
Consolidative use of radiotherapy to block oligoprogression in patients with metastatic melanoma on Systemic Therapy (CURB-Melanoma) - a single arm, phase 2 clinical trial.
Journal: Frontiers in oncology
Published: March 27, 2026
Phase 1 multicenter study of the NKG2A targeting antibody S095029 as a single agent and in combination with anti-PD-1 in patients with advanced malignancies.
Journal: Journal for immunotherapy of cancer
Published: March 26, 2026
Impact of metastasis-directed therapy for metachronous thoracic metastases following definitive (chemo)radiotherapy in p16-positive head and neck squamous cell carcinoma.
Journal: Oral oncology
Published: February 17, 2026
Pan-Cancer Pre-Treatment ctDNA Detection Using a Highly Sensitive Tumor-Informed Assay.
Journal: International journal of molecular sciences
Published: February 14, 2026
Practices and Impressions of Head and Neck Cancer Multidisciplinary Tumor Boards Findings From an American Head and Neck Society Survey.
Journal: Head & neck
Published: February 08, 2026
Longitudinal validation of ENLIGHT, an AI predictor of immunotherapy response and resistance, in pan-cancer cohorts.
Journal: NPJ precision oncology
Published: January 26, 2026
Genetically proxied inhibition of cholesterol-lowering drug targets and survival in HPV-positive and non-HPV driven head and neck cancer: a multicentre MR study.
Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Published: January 17, 2026
CANLead: Canada as a Phase 1 Clinical Trial Leader - Opportunities, Initiatives, and Collaborative Innovation to Elevate National Competitiveness.
Journal: The oncologist
Published: November 24, 2025
Predicting immunotherapy benefit in leiomyosarcoma through active chromatin cfDNA profiling.
Journal: NPJ precision oncology
Published: November 04, 2025
Last Updated: 09/26/2026